Tickers

1. Composite Trajectory Verdict

All three statements carry roughly equal weight: the income statement shows operating margin expansion and revenue growth, the cash flow statement demonstrates a swing to strong positive operating cash generation, and the balance sheet reflects dramatic deleveraging and equity recovery.

Composite Trajectory: Improving

Operating income improved from a $403 million loss in FY2024 to $2.33 billion in FY2025 and $4.45 billion in FY2026 (10-K FY2026, Consolidated Statements of Operations). Gross margin expanded from 28.1% to 38.8% to 48.9% over the same three years (10-K FY2026, MD&A). Net cash provided by operating activities swung from -$294 million in FY2024 to $1.69 billion in FY2025 and $3.93 billion in FY2026 (10-K FY2026, Consolidated Statements of Cash Flows). Total debt fell from $4.75 billion at June 27, 2025 to $1.06 billion at July 3, 2026, while shareholders' equity rose from $5.31 billion to $8.86 billion (10-K FY2026, Consolidated Balance Sheets). Quarterly trends confirm the trajectory: Q3 FY2026 revenue grew 45% year-over-year to $3.34 billion with 50.2% gross margin, versus $2.29 billion and 39.8% in Q3 FY2025 (10-Q Q3 FY2026, MD&A).

2. Red Flags

• Non-operating gains dominate net income: FY2026 net income of $9.42 billion includes a $6.50 billion mark-to-market gain on the retained Sandisk interest, versus a $772 million loss in FY2025 (10-K FY2026, Consolidated Statements of Operations). Excluding this, operating income was $4.45 billion.
• Large share repurchases funded partly by new borrowing: $2.59 billion of repurchases in FY2026 were partially financed by $1.95 billion of bridge loan and revolver proceeds (10-K FY2026, Consolidated Statements of Cash Flows).
• Customer concentration rising: Top 3 customers accounted for 44% of FY2026 revenue (16%, 15%, 13%) versus 39% in FY2025 (17%, 12%, 10%) and no single customer ≥10% in FY2024 (10-K FY2026, MD&A).
• Significant unrecognized tax benefits: $610 million liability as of July 3, 2026, with $349 million potentially payable within 12 months (10-K FY2026, Note 9).
• Convertible notes conversion overhang: $710 million of 2028 Convertible Notes remain outstanding, with $343 million already tendered for conversion and the remainder likely to be tendered, requiring ~$710 million cash for principal (10-K FY2026, MD&A – Short- and Long-term Liquidity).
• Global Minimum Tax accruals building: $89 million accrued as of July 3, 2026, not payable until Q2 2028 (10-K FY2026, Note 9).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Revenue grew 105% over two years, from $6.32 billion in FY2024 to $9.52 billion in FY2025 (51% YoY) and $12.92 billion in FY2026 (36% YoY) (10-K FY2026, Consolidated Statements of Operations). Gross margin expanded 20.8 percentage points over the same span: 28.1% → 38.8% → 48.9% (10-K FY2026, MD&A). Operating income swung from -$403 million (FY2024) to $2.33 billion (FY2025) to $4.45 billion (FY2026) (10-K FY2026, Consolidated Statements of Operations). R&D and SG&A as a percentage of revenue declined: R&D from 15.0% to 10.4% to 9.0%; SG&A from 11.5% to 6.0% to 4.3% (10-K FY2026, Consolidated Statements of Operations). Quarterly data corroborates: Q3 FY2026 gross margin 50.2% vs 39.8% in Q3 FY2025; operating margin 35.7% vs 33.1% (10-Q Q3 FY2026, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash from operations improved from -$294 million in FY2024 to $1.69 billion in FY2025 and $3.93 billion in FY2026 (10-K FY2026, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow minus capex) moved from -$781 million to $1.28 billion to $3.51 billion over the three years (capex: $487M, $412M, $418M respectively per 10-K FY2026, Consolidated Statements of Cash Flows). Nine-month operating cash flow rose from $945 million (9M FY2025) to $2.54 billion (9M FY2026) (10-Q Q3 FY2026, MD&A). The cash conversion cycle shows working capital absorption: FY2026 saw $541 million AR increase, $218 million inventory build, partially offset by $385 million AP increase (10-K FY2026, MD&A). Cash balance declined to $1.58 billion from $2.11 billion due to $2.59 billion share repurchases and $1.66 billion debt repayments (10-K FY2026, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total debt dropped 78% from $4.75 billion at June 27, 2025 to $1.06 billion at July 3, 2026 (10-K FY2026, Consolidated Balance Sheets). Long-term debt was eliminated entirely ($0 vs $2.49 billion). Shareholders' equity rose 67% from $5.31 billion to $8.86 billion, driven by $9.42 billion net income and $2.59 billion share repurchases (10-K FY2026, Consolidated Statements of Convertible Preferred Stock and Shareholders' Equity). The current portion of debt is $1.05 billion (mostly 2028 Convertible Notes), with $350 million revolver drawn and $900 million available (10-K FY2026, Note 7). Net leverage (debt minus cash / EBITDA proxy) improved markedly. Goodwill stable at $4.32 billion; no impairment recorded in FY2024-2026 (10-K FY2026, Note 5). Accrued tax liabilities and unrecognized tax benefits remain elevated at $740 million combined (10-K FY2026, Note 9).

6. Data Gaps

• Standalone Q4 FY2026 results (only full-year FY2026 and 9-month FY2026 are available; Q4 would require subtracting 9M from FY)
• Q1 and Q2 FY2026 quarterly statements (10-Qs for periods ended 2025-10-03 and 2026-01-02 are listed but not provided in the filings)
• FY2023 annual results for longer-term trend context
• Segment-level cash flow and balance sheet detail (only consolidated HDD segment presented post-Separation)
• Breakdown of "Other non-current assets" ($1.43 billion) and "Other liabilities" ($757 million) beyond what is in Note 5